Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,970.00p
   
  • Change Today:
      70.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 3,343
  • Market Cap: £155.18m

Latest Deals

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £8,823,514
Ian James Nicholson 13,000 £386,100
Bruce Hiscock 1,236 £36,709

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £155,023,783
Castlefield Fund Partners Limited 985,000 £29,254,500
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £26,284,500
Gresham House Asset Management Limited 627,782 £18,645,125
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £18,399,150
Miton Group plc 508,135 £15,091,610
The Diverse Income Trust plc 302,300 £8,978,310
Schroders plc 284,795 £8,458,412
Wasatch Advisors, Inc. 265,000 £7,870,500
Canaccord Genuity Group Inc 259,940 £7,720,218
Adrian Williams 253,372 £7,525,148

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,970.00p
Change Today 70.00p
% Change 2.41 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 3,343
Shares Issued 5.22m
Market Cap £155.18m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.27% below the market average25.27% below the market average25.27% below the market average25.27% below the market average25.27% below the market average
31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average
Price Trend
59.87% below the market average59.87% below the market average59.87% below the market average59.87% below the market average59.87% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average
Income
39.70% above the market average39.70% above the market average39.70% above the market average39.70% above the market average39.70% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
15.38% below the market average15.38% below the market average15.38% below the market average15.38% below the market average15.38% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 27-May-2025

Time Volume / Share Price
16:35 3 @ 2,970.00p
16:35 3 @ 2,970.00p
16:11 262 @ 2,848.00p
15:46 161 @ 2,840.00p
15:42 332 @ 2,805.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page